Russia said Tuesday, November 24 that its Sputnik V vaccine against the Covid-19 disease, developed by the Gamaleïa research center in Moscow, was 95% effective.
Read also: Covid-19: Agnès Pannier-Runacher, chief negotiator on vaccines
These are the preliminary results obtained on volunteers 42 days after the injection of the first dose, said in a statement this center, the Russian Ministry of Health and the Russian Sovereign Fund, involved in the development of this vaccine.
However, they did not mention the number of cases used for the calculations.